BioShares Biotechnology Products Fund ETF Forecast
BioShares Biotechnology Products Fund ETF price ended at $56.61 on Thursday, after gaining 0.415%.
(Updated on Mar 28, 2024)
The BioShares Biotechnology Products Fund ETF price gained 0.415% on the last trading day (Thursday, 28th Mar 2024), rising from $56.38 to $56.61. During the last trading day the ETF fluctuated 0.89% from a day low at $56.61 to a day high of $57.11. The price has risen in 6 of the last 10 days and is up by 2.4% over the past 2 weeks. Volume fell on the last day by -4 thousand shares and in total, 2 thousand shares were bought and sold for approximately $122.90 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The ETF lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the ETF is expected to fall -2.37% during the next 3 months and, with a 90% probability hold a price between $53.73 and $61.22 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BBP Signals & Forecast
There are mixed signals in the ETF today. The BioShares Biotechnology Products Fund ETF holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the ETF giving a more negative forecast for the stock. On further gains, the ETF will meet resistance from the long-term Moving Average at $58.38. On a fall, the ETF will find some support from the short-term average at $56.25. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Thursday, March 14, 2024, and so far it has risen 2.40%. Further rise is indicated until a new top pivot has been found. The ETF had a Golden Star Signal on Monday, September 11, 2023 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Golden Star 12 Months
The ETF had a Golden Star Signal on Monday, September 11, 2023 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Support, Risk & Stop-loss for BioShares Biotechnology Products Fund ETF
BioShares Biotechnology Products Fund finds support from accumulated volume at $56.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.501 between high and low, or 0.89%. For the last week the ETF has had daily average volatility of 0.91%.
Our recommended stop-loss: $53.74 (-5.06%) (This ETF has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)
Trading Expectations (BBP) For The Upcoming Trading Day Of Monday 1st
For the upcoming trading day on Monday, 1st we expect BioShares Biotechnology Products Fund to open at $56.78, and during the day (based on 14 day Average True Range), to move between $55.72 and $57.50, which gives a possible trading interval of +/-$0.89 (+/-1.57%) up or down from last closing price. If BioShares Biotechnology Products Fund takes out the full calculated possible swing range there will be an estimated 3.13% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $56.52 (0.16%) than the resistance at $58.63 (3.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is BioShares Biotechnology Products Fund ETF A Buy?
BioShares Biotechnology Products Fund holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.174 Hold/Accumulate Unchanged
Predicted Opening Price for BioShares Biotechnology Products Fund of Monday, April 1, 2024
Fair opening price April 1, 2024 | Current price |
---|---|
$56.78 ( 0.295%) | $56.61 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BBP
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 57.28 | 1.18 % | |
R2 | 57.09 | 0.84 % | ||
R1 | 56.97 | 0.633 % | ||
Current price: | 56.61 | |||
Support | S1 | 56.58 | -0.0431 % | |
S2 | 56.47 | -0.252 % | ||
S3 | 56.27 | -0.590 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 59.69 | 5.44 % | |
R2 | 58.66 | 3.62 % | ||
R1 | 58.63 | 3.57 % | ||
Current price | 56.61 | |||
Support | S1 | 56.52 | -0.157% | |
S2 | 56.38 | -0.413% | ||
S3 | 55.58 | -1.82% |
BBP Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | Dec 19, 2017 | Dec 20, 2017 | Dec 27, 2017 | $0.0720 | 0.176% |
2 | Dec 21, 2015 | Dec 21, 2015 | Dec 29, 2015 | $0.397 | 1.27% |
FAQ
Click here for our free guide on how to buy BioShares Biotechnology Products Fund ETF.